JenaValve Appoints Duane Pinto, MD, MPH, as Chief Medical

IRVINE, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve...

Related Keywords

Germany ,Qatar ,California ,United States ,Munich ,Bayern ,Irvine ,Duane Pinto ,John Kilcoyne ,Medicine At Harvard Medical School ,Bain Capital Life Sciences ,Dartmouth College ,Beth Israel Deaconess Medical Center ,Qatar Investment Authority ,Jenavalve Technology Inc ,Peijia Medical ,Valiance Life Sciences ,Georgetown University ,Company Trilogy ,Valve Technology ,Chief Medical ,Harvard Medical School ,Interventional Cardiology ,Beth Israel Deaconess Medical ,Chief Executive ,Heart Valve System ,Biological Sciences ,Clinical Effectiveness ,Harvard Th Chan School ,Trilogy System ,Breakthrough Device Designation ,Trilogy Heart Valve System ,Andera Partners ,Edmond De Rothschild Investment Partners ,Cormorant Asset Management ,Legend Capital ,Neomed Management ,Pictet Alternative Advisors ,Innovatus Capital Partners ,Jenavalve Technology ,Nc ,